Will HEXO (TSX:HEXO) Kill Canopy Growth (TSX:WEED) Stock?

Learn how HEXO Corp. (TSX:HEXO)(NYSE:HEXO) is building a differentiated cannabis platform capable of killing large pot producers like Canopy Growth Corp. (TSX:WEED)(NYSE:CGC).

| More on:
question marks written reminders tickets

Image source: Getty Images

HEXO Corp. (TSX:HEXO)(NYSE:HEXO) was once cannabis royalty. In just three years, the stock rose from $0.50 to $10. The recent marijuana pullback has hampered expectations, but HEXO’s management team continues to invest in its long-term strategy.

If successful, HEXO’s differentiated approach could spell trouble for other pot stocks, namely Canopy Growth Corp. (TSX:WEED)(NYSE:CGC). That’s because HEXO is creating a scalable cannabis platform, while peers like Canopy are betting they can dominate the market alone.

Will HEXO eventually kill cannabis competitors like Canopy? First, we’ll need to dig into its platform approach.

Platform and win

Platforms are powerful, just ask big tech. Over the years, Shopify Inc. and Microsoft Corporation have mastered the art of platforming. Since cracking the code, both stocks are up by more than 1,000%.

What is platforming? It’s exactly what it sounds like: building a platform so other things can be built on top of it. In the case of Microsoft, its Windows platform enables every application and activity that PC users use. For Shopify, it’s all of the businesses and third-party features built on top of its e-commerce platform.

Take away the platforms and everything else disappears. That results in extreme levels of stickiness and customer retention. It also encourages development.

Companies can build and monetize software for Windows and Shopify users without needing to build or maintain the underlying operating system. That’s a huge plus.

HEXO is applying the tech approach of platforming to the cannabis industry. Most pot companies are completely relying on themselves to grow, package, brand, and distribute cannabis products. That’s not a platform.

HEXO, meanwhile, is simply building the base infrastructure, allowing other companies to build on top of it. Now that’s a platform.

Here’s an example. HEXO currently has its basic infrastructure in place, including a 1.7 million square feet of grow facilities, a 730,000 square feet processing center, a 34,000 square feet of research and development space, and a 59,000 distribution centre.

This year HEXO partnered with Molson Coors Canada Inc. to co-create cannabis-infused beverages. The joint venture will fuse HEXO’s cannabis infrastructure with Molson’s existing brand and marketing power.

This is the power of HEXO’s platform model. Rather than building brands from scratch, it can tap into pre-existing global powerhouses.

Molson doesn’t need to build its own cannabis infrastructure, while HEXO can leverage Molson’s reputation and reach. HEXO is allowing any outside company to partner with it, and next year, it wants to create joint ventures targeting cosmetics, sleep aids, edibles, and more.

A tougher path

Under its differentiated platform model, HEXO could potentially partner with dozens of Fortune 500 companies, including Molson, Coca-Cola Co, Nestle SA, Danone SA, L’Oreal SA, and many more. How does that compare to a competitor like Canopy Growth?

Canopy already has an exclusive partner, Constellation Brands, Inc. (NYSE:STZ), which has invested more than $4 billion in the company.

Constellation is a powerhouse in its own right, owning globally-recognized brands like Corona, Modelo, and Robert Mondavi wines. It’s the third-largest beer supplier in the U.S.

But no matter how powerful Constellation is, it’s still just one company. HEXO, by comparison, can partner with dozens.

This December, HEXO and Molson plan on selling their first CBD-infused beverage products in Canada, shortly followed by THC-based versions.

HEXO, of course, would like these products to succeed, but even if they fail, it can partner with additional brands to experiment with other form factors. Canopy doesn’t have such an advantage given it can only sell what Constellation prefers.

The alcohol market has annual worldwide sales exceeding $1 trillion. Cannabis beverages have the potential to rival this figure, far outpacing sales of traditional cannabis flowers and concentrates.

If I’m betting on a company to capitalize, my money would be on HEXO’s platform model, not Canopy’s exclusive partnership.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Teresa Kersten, an employee of LinkedIn, a Microsoft subsidiary, is a member of The Motley Fool’s board of directors. The Motley Fool owns shares of and recommends Microsoft, Shopify, and Shopify. The Motley Fool recommends HEXO., HEXO., and Nestle and recommends the following options: long January 2021 $85 calls on Microsoft. Fool contributor Ryan Vanzo has no position in any stocks mentioned. Shopify is a recommendation of Stock Advisor Canada.

More on Cannabis Stocks

Pot stocks are a riskier investment
Cannabis Stocks

Is the Worst Over for Canopy Growth Stock?

Down 99% from all-time highs Canopy Growth stock has burnt investor wealth and remains a high-risk investment.

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Steer Clear: This Stock Spells Trouble

A newly listed cannabis stock is outperforming in 2024 but investors should stay clear to avoid trouble and losses.

Read more »

Cannabis stocks have fallen.
Cannabis Stocks

2 Best Marijuana Stocks to Buy This Month

Marijuana stocks in the U.S. such as Green Thumb and Curaleaf can help you deliver outsized gains to investors in…

Read more »

A cannabis plant grows.
Cannabis Stocks

Can Aurora Cannabis Stock Recover in 2024?

Aurora Cannabis stock is down 99% from all-time highs but remains a high-risk bet, despite its cheap valuation.

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

The Best Cannabis Stock to Buy Right Now

This cannabis stock has jumped 30% in the last few months, with even more growth on the way – all…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Down 99% From All-Time Highs, Is Canopy Growth Stock a Good Buy Right Now?

Canopy Growth stock is a high-risk investment due to its negative profit margins and challenging liquidity position.

Read more »

Marijuana plant and cannabis oil bottles isolated
Stocks for Beginners

Aurora Cannabis’ Reverse Stock Split: Is the Stock a Buy Today?

Cannabis stock Aurora (TSX:ACB) is consolidating shares once again, but what does this mean for investors?

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Where Will Cannabis Stocks Be in 10 Years?

Cannabis stocks could see a huge shift upwards should marijuana be rescheduled in the U.S., but you can still buy…

Read more »